6MAW

F9 Pilus Adhesin FmlH Lectin Domain from E. coli UTI89 in Complex with Galactoside N-[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[S-methyl-6-(trifluoromethyl)-[1,1'-biphenyl]-3'-yl]oxy}oxan-3-yl]acetamide

Summary for 6MAW

Entry DOI	10.2210/pdb6maw/pdb
Descriptor	Fimbrial adhesin FmlD, N-[2'-{[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy}-6'-(trifluoromethyl)[1,1'-biphenyl]-3-yl]methanesulfonamide (3 entities in total)
Functional Keywords	pilus, adhesin, galactose, lectin, sugar binding protein, sugar binding protein-inhibitor complex, sugar binding protein/inhibitor
Biological source	Escherichia coli UTI89
Total number of polymer chains	1
Total formula weight	18454.59
Authors	Klein, R.D.,Hultgren, S.J. (deposition date: 2018-08-28, release date: 2019-09-04, Last modification date: 2023-12-13)
Primary citation	Maddirala, A.R.,Klein, R.,Pinkner, J.S.,Kalas, V.,Hultgren, S.J.,Janetka, J.W. Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. J.Med.Chem., 62:467-479, 2019 Cited by PubMed: 30540910 DOI: 10.1021/acs.jmedchem.8b01561 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.75 Å)

Structure validation